Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study Source: Eur Respir J 2013; 42: 98-106 Year: 2013
Exhaled carbon monoxide in asthma: a prospective study Source: Eur Respir J 2003; 22: Suppl. 45, 413s Year: 2003
Asthma exacerbations and exhaled nitric oxide: a randomised controlled trial Source: Eur Respir J 2006; 28: Suppl. 50, 572s Year: 2006
Adult lung function and long-term air pollution exposure. ESCAPE: a multicentre cohort study and meta-analysis Source: Eur Respir J 2015; 45: 38-50 Year: 2015
Asthma rehabilitation at high vs. low altitude and its impact on exhaled nitric oxide and sensitization patterns: randomized parallel-group trial Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018
ß-blockers in exacerbations of COPD: feasibility of a randomised controlled trial Source: ERJ Open Res, 3 (1) 00090-2016; 10.1183/23120541.00090-2016 Year: 2017
Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort Source: Eur Respir J, 57 (2) 2002127; 10.1183/13993003.02127-2020 Year: 2021
Volatile organic compounds exposure and respiratory function in preschoolers from mothers whose participated in a randomized clinical trial during pregnancy Source: Annual Congress 2012 - Environmental exposure and other risk factors for airway diseases Year: 2012
Ozone exposure leads to changes in airway permeability, microbiota and metabolome: a randomised, double-blind, crossover trial Source: Eur Respir J, 56 (3) 2000165; 10.1183/13993003.00165-2020 Year: 2020
Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial Source: Eur Respir J, 51 (1) 1701926; 10.1183/13993003.01926-2017 Year: 2018
Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT? Source: ERJ Open Res 2016: 00055-2016 Year: 2016
Breath volatile organic compound (VOC) patterns in adult asthma patients of the ALLIANCE cohort Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019
Cigarette smoke retention and bronchodilation in patients with COPD: A controlled randomized trial Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012
A randomised double-blind placebo-controlled trial of the effect of inhaled heparin on lung function, hyperinflation and exercise capacity in patients with COPD Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016
Oxygen compared to air driven nebulisers for acute exacerbations of COPD: a randomised controlled trial. Source: International Congress 2017 – COPD management Year: 2017
A double-blind randomised controlled trial of protein supplementation to enhance exercise capacity in COPD during pulmonary rehabilitation: a pilot study Source: ERJ Open Res, 7 (1) 00077-2021; 10.1183/23120541.00077-2021 Year: 2021
Helium-oxygen gas mixtures in infants with acute bronchiolitis: results of a phase III double-blind, multicentre RCT Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood Year: 2009
The evaluation of the efficacy and safety of phospholipids‘ inhalation in patients with bronchial asthma (BA): A prospective randomized placebo-controlled study Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012
Supplemental dietary nitrate for COPD: A randomized, double-blind, placebo-controlled, crossover trial Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation Year: 2013
Effects of a home programme of airway clearance techniques on adventitious respiratory sounds in patients with bronchiectasis: a randomised controlled trial Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) Year: 2018